======= FLII ======= == Gene Information == * **Official Symbol**: FLII * **Official Name**: FLII actin remodeling protein * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=2314|2314]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q13045|Q13045]] * **Interactions**: [[https://thebiogrid.org/search.php?search=FLII&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20FLII|Open PubMed]] * **OMIM**: [[https://omim.org/entry/600362|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a protein with a gelsolin-like actin binding domain and an N-terminal leucine-rich repeat-protein protein interaction domain. The protein is similar to a Drosophila protein involved in early embryogenesis and the structural organization of indirect flight muscle. The gene is located within the Smith-Magenis syndrome region on chromosome 17. [provided by RefSeq, Jul 2008]. * **UniProt Summary**: May play a role as coactivator in transcriptional activation by hormone-activated nuclear receptors (NR) and acts in cooperation with NCOA2 and CARM1. Involved in estrogen hormone signaling. Involved in early embryonic development (By similarity). May play a role in regulation of cytoskeletal rearrangements involved in cytokinesis and cell migration, by inhibiting Rac1-dependent paxillin phosphorylation. {ECO:0000250, ECO:0000269|PubMed:14966289}. |LRR 4| |Gelsolin| |actin filament severing| |brush border| |microtubule organizing center| |actin filament binding| |actin binding| |focal adhesion| |actin cytoskeleton organization| |actin filament-based process| |cytoskeleton organization| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp226|Cerivastatin 0.15μM R05 exp226]]|-2.26| |[[:results:exp125|GSK461364A 0.005μM R03 exp125]]|-2.02| |[[:results:exp215|Colchicine 0.009μM R05 exp215]]|1.85| |[[:results:exp343|Centrinone 0.5μM R07 exp343]]|1.87| |[[:results:exp472|CI-1040 9.5μM R08 exp472]]|2| |[[:results:exp106|UM131593 0.2μM R03 exp106]]|3.44| |[[:results:exp72|LB-100 4.1μM R02 exp72]]|3.95| ^Gene^Correlation^ |[[:human genes:p:pfn1|PFN1]]|0.469| Global Fraction of Cell Lines Where Essential: 32/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|1/28| |blood|2/28| |bone|0/26| |breast|2/33| |central nervous system|1/56| |cervix|0/4| |colorectal|1/17| |esophagus|1/13| |fibroblast|0/1| |gastric|1/16| |kidney|0/21| |liver|0/20| |lung|2/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|4/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|1/9| |thyroid|1/2| |upper aerodigestive|0/22| |urinary tract|7/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 2535 * **Expression level (log2 read counts)**: 7.11 {{:chemogenomics:nalm6 dist.png?nolink |}}